Skip to main content

Celera Diagnostics and UCSF in Breast Cancer Marker Collaboration

NEW YORK, Nov. 7-Researchers at Celera Diagnostics and the University of California, San Francisco will work together to identify genetic markers for breast cancer, the company said today.

 

The collaboration is a large-scale disease association study pairing Celera and UCSF's Comprehensive Cancer Center. Celera Diagnostics and the UC president's office Industry-University Cooperative Research Program will jointly pay for the project.

 

Financial and intellectual property details of the research partnership were not revealed.

 

For further details, see the company statement.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.